Suan Tsao Jen Tang for Treating Menopause With Sleep Problem: a Clinical Observation
1 other identifier
observational
67
1 country
1
Brief Summary
A prospective follow-up study was carried out in the Yang Ming branch of the Taipei City Hospital.Climacteric women with sleep difficulty received SZRT at a rate of 4.0 g, thrice daily for four weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 20, 2010
CompletedFirst Posted
Study publicly available on registry
December 28, 2010
CompletedDecember 28, 2010
January 1, 2008
2 years
December 20, 2010
December 27, 2010
Conditions
Keywords
Eligibility Criteria
The subjects enrolled in the study were climacteric women, ranging from 40-65 years of age, with a Pittsburg Sleep Quality Index (PSQI) of greater than six. These women spent 45 minutes or more falling asleep, slept less than six hours, and had struggled with this issue continuously for at least one month.
You may qualify if:
- Climacteric women, ranging from 40-65 years of age
- Pittsburg Sleep Quality Index (PSQI) of greater than six
- Falling asleep more than 45 minutes or slept less than six hours
You may not qualify if:
- Within three months of the study there had been a major incident
- Working the nightshift
- Lack of time or timing conflicts
- Pychosis, severe depression, obstructive sleep apnea-hypopnea, cardiac arrhythmia, acute myocardial infarction, high blood pressure, diabetes, or cancer
- Currently taking pharmaceuticals that affect melatonin, acetylcholine, glutamate, serotonin, norepinephrine, GABA, histamine, adenosine, or prostaglandins
- Inability to read and fill out the forms for the study
- Any evidence of renal or liver dysfunction as defined by a level of at least 1.5 times of the upper reference limit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taipei City Hospitallead
- Chinese Medical Associationcollaborator
Study Sites (1)
Taipei City Hospital
Taipei, Taiwan, 111, Taiwan
Study Officials
- STUDY CHAIR
Jung-Nien Lai, PHD
Taipei City Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
December 20, 2010
First Posted
December 28, 2010
Study Start
April 1, 2008
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
December 28, 2010
Record last verified: 2008-01